A unidirectional crosslinking strategy for HIV-1 protease dimerization inhibitors
- 1 August 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (16) , 4297-4300
- https://doi.org/10.1016/j.bmcl.2004.05.081
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A unidirectional crosslinking strategy for HIV-1 protease dimerization inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- Modulation of Protein–Protein Interactions with Small Organic MoleculesAngewandte Chemie International Edition in English, 2003
- Inhibition of Protein−Protein Association by Small Molecules: Approaches and ProgressJournal of Medicinal Chemistry, 2002
- Novel strategies for targeting the dimerization interface of HIV protease with cross‐linked interfacial peptidesPeptide Science, 2002
- INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug DesignAnnual Review of Biophysics, 1998
- Targeting the Dimerization Interface of HIV-1 Protease: Inhibition with Cross-Linked Interfacial PeptidesJournal of the American Chemical Society, 1997
- Identification of a clinical isolate of HIV-1 with an isoleucine at position 82 of the protease which retains susceptibility to protease inhibitorsAntiviral Research, 1995
- A simple, continuous fluorometric assay for HIV proteaseInternational Journal of Peptide and Protein Research, 1990
- All‐D‐magainin: chirality, antimicrobial activity and proteolytic resistanceFEBS Letters, 1990
- Establishment of a new short, protease-resistant, affinity labeling reagent for the cholecystokinin receptorBiochemical and Biophysical Research Communications, 1987